Transforming Care Lead – Respiratory and Immunology (R&I)
Added 13 Oct · still live
Not disclosed
Salary
Not disclosed by employer
£50,300
Going rate
Skilled Worker going rate
This role may qualify for a Skilled Worker visa
SOC 1171 is an eligible occupation, but we are only 53% sure that is the right code. AstraZeneca is a licensed sponsor, so if the code fits, the role should qualify. Check the occupation eligibility rules against what the job actually involves.
This could also be SOC 2259 (Other health professionals not elsewhere classified) or SOC 2431 (Management consultants and business analysts). We read the code off the advert, so it is our best guess, not the employer's.
About the role
Position: Transforming Care Lead – Respiratory and Immunology (R&I)
Location: Field-based, UK
Competitive Salary & Excellent Company Benefits
Applications Closing Date: 2 November 2026
Introduction to the Role
At AstraZeneca UK, Medical & Scientific Affairs plays a pivotal role in improving patient outcomes by working collaboratively with NHS partners to support meaningful and sustainable changes in healthcare delivery.
As Transforming Care Lead – Respiratory and Immunology (R&I), you will lead the development and implementation of the R&I transforming care strategy.
Working in partnership with therapy-area Medical and Brand teams, you will help ensure NHS systems are ready to identify, diagnose and optimally manage relevant patients ahead of, and throughout, the launch period.
Using population health and pathways expertise, you will accelerate the implementation of guideline-directed care at scale across respiratory and immunology pathways. You will identify pathway, diagnostic and capacity gaps, prioritise opportunities using population health data and drive improvements across clinical systems, medicines optimisation, care pathways and collaborative working models.
The role operates on a non-promotional medical basis. You will work closely with Brand and Commercial colleagues while retaining independent medical judgement and ensuring that supported system changes are clinically appropriate, evidence-based and aligned with the needs of patients and NHS systems.
Key Accountabilities
Transforming Care Strategy and System Readiness
You will partner with R&I Medical and Brand teams to define the therapy-area transforming care strategy and lead the development and delivery of system readiness plans for R&I launches. This will involve assessing pathway, diagnostic and capacity gaps, sequencing the changes required and reporting readiness status through launch governance.
You will direct the use of linked datasets, secure data environments and NHS data partnerships to identify the populations and health systems where intervention is most likely to deliver meaningful impact. Your approach will be evidence-led, prioritising opportunities according to population need and potential system impact rather than responding solely to inbound requests.
You will ensure that pathways, clinical systems, medicines optimisation and collaborative working initiatives are aligned to the R&I transforming care strategy. You will build a strong network of external expert partners to provide insight into the changing NHS landscape and identify future opportunities for AstraZeneca UK to collaborate on transforming care projects.
A key part of the role will be gathering and interpreting population health analytics at national, system and local levels. You will integrate new providers into relevant local or national projects and ensure that every transforming care initiative has a clearly defined evaluation approach, including agreed baselines and outcome measures at the design stage.
You will share evaluation findings internally and, where appropriate, support publication or external presentation of outcomes. You will also be accountable for the R&I transforming care budget, prioritising investment across initiatives to maximise system impact.
Implementation of Population Health and Pathways Initiatives
Location: Field-based, UK
Competitive Salary & Excellent Company Benefits
Applications Closing Date: 2 November 2026
Introduction to the Role
At AstraZeneca UK, Medical & Scientific Affairs plays a pivotal role in improving patient outcomes by working collaboratively with NHS partners to support meaningful and sustainable changes in healthcare delivery.
As Transforming Care Lead – Respiratory and Immunology (R&I), you will lead the development and implementation of the R&I transforming care strategy.
Working in partnership with therapy-area Medical and Brand teams, you will help ensure NHS systems are ready to identify, diagnose and optimally manage relevant patients ahead of, and throughout, the launch period.
Using population health and pathways expertise, you will accelerate the implementation of guideline-directed care at scale across respiratory and immunology pathways. You will identify pathway, diagnostic and capacity gaps, prioritise opportunities using population health data and drive improvements across clinical systems, medicines optimisation, care pathways and collaborative working models.
The role operates on a non-promotional medical basis. You will work closely with Brand and Commercial colleagues while retaining independent medical judgement and ensuring that supported system changes are clinically appropriate, evidence-based and aligned with the needs of patients and NHS systems.
Key Accountabilities
Transforming Care Strategy and System Readiness
You will partner with R&I Medical and Brand teams to define the therapy-area transforming care strategy and lead the development and delivery of system readiness plans for R&I launches. This will involve assessing pathway, diagnostic and capacity gaps, sequencing the changes required and reporting readiness status through launch governance.
You will direct the use of linked datasets, secure data environments and NHS data partnerships to identify the populations and health systems where intervention is most likely to deliver meaningful impact. Your approach will be evidence-led, prioritising opportunities according to population need and potential system impact rather than responding solely to inbound requests.
You will ensure that pathways, clinical systems, medicines optimisation and collaborative working initiatives are aligned to the R&I transforming care strategy. You will build a strong network of external expert partners to provide insight into the changing NHS landscape and identify future opportunities for AstraZeneca UK to collaborate on transforming care projects.
A key part of the role will be gathering and interpreting population health analytics at national, system and local levels. You will integrate new providers into relevant local or national projects and ensure that every transforming care initiative has a clearly defined evaluation approach, including agreed baselines and outcome measures at the design stage.
You will share evaluation findings internally and, where appropriate, support publication or external presentation of outcomes. You will also be accountable for the R&I transforming care budget, prioritising investment across initiatives to maximise system impact.
Implementation of Population Health and Pathways Initiatives
Advertisement
You will lead the implementation of population health and pathways initiatives across respiratory and immunology clinical systems, medicines optimisation, patient pathways and collaborative working models.
You will ensure that initiatives are joined up, coordinated and strategically aligned with the transforming care strategy. This will require close collaboration with field medical team managers and alignment across internal stakeholders, including Senior Leadership Team members, Franchise Heads and Heads of Medical.
You will define, prioritise and communicate the Population Health and Pathways book of work, ensuring that activity is appropriately resourced, strategically aligned and clearly understood across the organisation. You will work with Medical and Brand teams to align the book of work with brand strategy while maintaining the non-promotional boundary of Population Health activity.
You will develop measurement frameworks to assess the impact of initiatives, monitor performance regularly and recommend improvements based on evidence and insight. You will ensure that all Population Health and Pathways activity complies with AstraZeneca UK standard operating procedures, governance requirements and the ABPI Code of Practice.
Team Leadership and Development
You will lead a therapy-area unit comprising a Clinical Services Manager, Data Manager and Pathways Managers. You will provide clear direction, assign accountability for delivery and compliance, and create a high-performing, integrated and collaborative team culture.
You will be responsible for leading, developing and performance-managing direct reports, including conducting regular performance and development reviews and addressing underperformance where required.
You will also play an active role in the Population Health and Pathways Leadership Team, contributing to the wider development of the function and sharing effective approaches across therapy areas.
Key Working Relationships
You will ensure that initiatives are joined up, coordinated and strategically aligned with the transforming care strategy. This will require close collaboration with field medical team managers and alignment across internal stakeholders, including Senior Leadership Team members, Franchise Heads and Heads of Medical.
You will define, prioritise and communicate the Population Health and Pathways book of work, ensuring that activity is appropriately resourced, strategically aligned and clearly understood across the organisation. You will work with Medical and Brand teams to align the book of work with brand strategy while maintaining the non-promotional boundary of Population Health activity.
You will develop measurement frameworks to assess the impact of initiatives, monitor performance regularly and recommend improvements based on evidence and insight. You will ensure that all Population Health and Pathways activity complies with AstraZeneca UK standard operating procedures, governance requirements and the ABPI Code of Practice.
Team Leadership and Development
You will lead a therapy-area unit comprising a Clinical Services Manager, Data Manager and Pathways Managers. You will provide clear direction, assign accountability for delivery and compliance, and create a high-performing, integrated and collaborative team culture.
You will be responsible for leading, developing and performance-managing direct reports, including conducting regular performance and development reviews and addressing underperformance where required.
You will also play an active role in the Population Health and Pathways Leadership Team, contributing to the wider development of the function and sharing effective approaches across therapy areas.
Key Working Relationships
Advertisement
You will work closely with the Population Health and Pathways team, R&I Brand Leads, Brand Medical Leads, Field Medical leadership, Market Access, Legal and Compliance colleagues.
Externally, you will build partnerships with NHS stakeholders and organisations, including Integrated Care Board executives, Clinical Directors, regional and national NHS teams, Health Innovation Networks and national programme partners.
Essential Experience And Skills
Externally, you will build partnerships with NHS stakeholders and organisations, including Integrated Care Board executives, Clinical Directors, regional and national NHS teams, Health Innovation Networks and national programme partners.
Essential Experience And Skills
- Demonstrable experience of developing and implementing therapy-area transformation strategies that improve patient outcomes, clinical pathways or healthcare delivery.
- Direct people-leadership experience, including team development, performance management and building a high-performing culture.
- Strong understanding of patient data and clinical systems across primary and secondary care.
- Hands-on experience delivering partnership projects with NHS stakeholders.
- Proven ability to influence and work collaboratively across organisational boundaries, including leadership without formal authority.
- Strong stakeholder engagement, communication and influencing skills.
- Experience driving transformation within the NHS, particularly across respiratory or immunology pathways.
- Experience in respiratory, immunology, severe asthma, COPD, asthma or related long-term condition therapy areas.
- Degree-level qualification or professional qualification in healthcare, clinical practice or a related scientific discipline, such as Medicine, Nursing, Pharmacy, Physician Associate studies or a related life-science subject.
- Experience designing, commissioning or evaluating service change.
- Experience building and managing strategic partnerships with senior NHS leaders, including Integrated Care Board executives, Clinical Directors and regional or national NHS teams.
This is an opportunity to play a leading role in shaping how respiratory and immunology care is delivered across the NHS. You will work at the intersection of population health, clinical pathways, healthcare innovation and medical strategy, helping systems identify unmet need and implement sustainable improvements that can make a meaningful difference to patients living with respiratory and immune-mediated conditions.
You will join a collaborative and purpose-driven Population Health and Pathways team, working across AstraZeneca and with NHS partners to translate evidence and insight into scalable improvements in care.
Additional Information
This is a home-based role, with an expectation to work from the AstraZeneca UK Head Office one to two days per week. The role will also require UK-wide travel to NHS partner sites and national meetings as needed.
Interested? Apply Now!
Date Posted
12-Oct-2026
Closing Date
02-Nov-2026
Our mission is to build an inclusive and equitable environment. We want people to feel they belong at AstraZeneca and Alexion, starting with our recruitment process. We welcome and consider applications from all qualified candidates, regardless of characteristics. We offer reasonable adjustments/accommodations to help all candidates to perform at their best. If you have a need for any adjustments/accommodations, please complete the section in the application form.
This description is the source posting as it read when we added it. We are not affiliated with AstraZeneca, so check their own site for the current details.
Where this offer sits in the market
Health services and public health managers and directors (SOC 1171) · UK · ONS ASHE 2025 · basic pay · ~51k in sampleSOC 1171
- Middle half £49,244–78,468
- Median £62,296
- Going rate £50,300
- Threshold £41,700
- New entrant £35,200–45,300
Similar sponsored roles
See all UK visa jobs- London, England, United Kingdom13 Oct
Strategy and Operations Lead, Medical & Scientific Affairs
AstraZeneca UK Limited · London, England, United Kingdom
- London, England, United Kingdom13 Oct
Transforming Care Lead – Cardiovascular, Renal and Metabolic (CVRM)
AstraZeneca UK Limited · London, England, United Kingdom
- London, England, United Kingdom13 Oct
Surgical Services Manager – Quality, Resus & ECU
Fortius London Limited · London, England, United Kingdom
- London, England, United Kingdom13 Oct
Surgical Services Manager – Clinical Operations
Fortius London Limited · London, England, United Kingdom
- London, England, United Kingdom13 Oct
General Manager
South London & Maudsley NHS Foundation Trust · London, England, United Kingdom
- London, England, United Kingdom13 Oct
SLP Clinical Director – Adult Eating Disorders
South London & Maudsley NHS Foundation Trust · London, England, United Kingdom
About sponsorship for this role
Does this job guarantee visa sponsorship?
Not necessarily. AstraZeneca holds a sponsor licence, but sponsorship for a specific hire is always the employer's decision. Be upfront in your application that you'll require it.
What salary is needed for this role to be eligible?
The offer must clear both the general threshold and the SOC 1171 going rate of £50,300. New-entrant and shortage discounts can lower it.